Cargando…
Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population
Common treatment options for deep vein thrombosis and venous thromboembolism in the pediatric population include unfractionated heparin, low molecular weight heparin, and warfarin. Other alternatives are bivalirudin, argatroban, and fondaparinux. Warfarin is the only approved oral option, but an ora...
Autores principales: | von Vajna, Erika, Alam, Ruhaniyah, So, Tsz-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906081/ https://www.ncbi.nlm.nih.gov/pubmed/26739579 http://dx.doi.org/10.1007/s40119-015-0054-y |
Ejemplares similares
-
Direct Oral Anticoagulants for Stroke Prevention in Special Populations: Beyond the Clinical Trials
por: Carbone, Andreina, et al.
Publicado: (2023) -
Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
por: Elhosseiny, Sherif, et al.
Publicado: (2019) -
Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population
por: Lim, Hui Yin, et al.
Publicado: (2016) -
What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future?
por: Betensky, Marisol, et al.
Publicado: (2023) -
Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)